Dr. Edmund Waller, MD
Claim this profileEmory University Hospital
Studies Acute Myelogenous Leukemia
Studies Acute Lymphoblastic Leukemia
15 reported clinical trials
22 drugs studied
Area of expertise
1Acute Myelogenous Leukemia
HLA-A positive
HLA-A negative
HLA positive
2Acute Lymphoblastic Leukemia
CD19 positive
HLA-A positive
HLA-A negative
Affiliated Hospitals
Clinical Trials Edmund Waller, MD is currently running
Influenza Vaccine
for Flu
The purpose of this study is to evaluate the immune response of the killed flu vaccine in healthy subjects. Participants in this study are considered to be healthy volunteers. Influenza ("Flu") infection carries a risk of serious illness. This is an open label and single arm observational study designed to assess the humoral response to influenza vaccination and the longevity of humoral immunity to influenza vaccination in healthy adults. Enrolled subjects will receive licensed seasonal inactivated influenza vaccine (administered as a part of the study). Participants will donate serial samples of blood and bone marrow aspirate for immunology monitoring. Repeated measurements of humoral immunity will be obtained at 7 days, 28 days, 90 days and at one year post vaccination to assess the magnitude, clonal diversity and persistence of B-cell responses to influenza vaccination.
Recruiting3 awards Phase 43 criteria
Mocravimod
for Acute Myeloid Leukemia
This is a multi-center, randomized, double-blinded, placebo controlled trial.
Recruiting1 award Phase 3
More about Edmund Waller, MD
Clinical Trial Related2 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Edmund Waller, MD has experience with
- Orca-T
- Fludarabine
- Duvelisib
- Tisagenlecleucel
- Influenza Vaccine
- Standard-of-Care
Breakdown of trials Edmund Waller, MD has run
Acute Myelogenous Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Edmund Waller, MD specialize in?
Edmund Waller, MD focuses on Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Edmund Waller, MD currently recruiting for clinical trials?
Yes, Edmund Waller, MD is currently recruiting for 5 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Edmund Waller, MD has studied deeply?
Yes, Edmund Waller, MD has studied treatments such as Orca-T, Fludarabine, Duvelisib.
What is the best way to schedule an appointment with Edmund Waller, MD?
Apply for one of the trials that Edmund Waller, MD is conducting.
What is the office address of Edmund Waller, MD?
The office of Edmund Waller, MD is located at: Emory University Hospital, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.